Mediolanum International Funds Limited (MIFL) is a management company approved by the Central Bank of Ireland to manage UCITS & Non UCITS Funds as well as the Research & Development (R&D) and funds product innovation centre (MedLab®) for the Mediolanum Banking Group.
MIFL undertakes significant proprietary R&D and collaborates with selected international partners, leveraging on its open innovation platform and proprietary process (MedInSynC®), with a view towards developing in house solutions tailored to meet clients’ needs. We believe this ensures that we can deliver value adding investment products and services to our predominantly European retail client base. MIFL is also one of the pioneers for the protection of Intellectual Property in the funds industry and is very active in shaping evolving market best practice in this area.
Our mission is to maintain and develop a European platform for funds within the Mediolanum Group able to deliver compelling and innovative investment solutions.
Many companies within our industry create a product in isolation and then think about “how to sell” the product to investors.
MIFL are proud to be a company who thinks first about what are our clients' needs, and then about how we will deliver solutions to meet those needs.
All of our products are actively managed and we seek to ensure that they provide solutions that never go “out of fashion”.
MIFL will continue to maintain the focus on our clients' needs, targeting the highest quality standards for our investments. We have created the three following pillars.